A gene-editing technique has shown promise in treating Duchenne muscular dystrophy (DMD), the most common and severe form of muscular dystrophy among boys which is characterised by progressive muscle degeneration and weakness.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
A gene-editing technique has shown promise in treating Duchenne muscular dystrophy (DMD), the most common and severe form of muscular dystrophy among boys which is characterised by progressive muscle degeneration and weakness.
Researchers have developed new polio vaccine strains that is particularly suitable for a post-eradication era as these strains appear both effective and unable to cause disease after accidental release.
Pharma major Cadila Healthcare on Thursday clarified that products from its Moraiya and Ahmedabad plants in Gujarat were safe in the market and effective.
Conventional drug seller may breathe sigh of relief as sale of drugs over Internet contravening the provisions of Drugs and Cosmetics Rules, 1945 as per notice by Joint drugs Controller. Drug authorities are requested to put a strict vigil on online sale of medicines and take action against those indulging in online sale of medicines in violation of the Drugs and Cosmetics Act and Rules.
Taking a high dose of vitamin D could be an inexpensive and easy way to treat people with multiple sclerosis (MS), an autoimmune disorder that affects the brain and spinal chord, suggests promising new research.
The city-based Asian Institute of Gastroenterology on Wednesday claimed that it successfully used a new technique for treatment of gastro-esophageal reflux disease (GERD), usually termed as acidity.
It has been decided by Government to establish risk based sampling of consignments for faster clearance of import and export at the ports/airports/other points of entry.
Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity, say researchers, including one of Indian-origin. A novel formulation of the drug propranolol as a liquid salt enables delivery through skin with reduced toxicity, the findings showed.
[adsense:336x280:8701650588]
BioMarin Pharmaceutical Inc. announced that the U.S. Food and Drug Administration (FDA) has notified the Company that they had not yet completed their review process and would be unable to take an action by the Prescription Drug User Fee Act (PDUFA) action date for KyndrisaTM (drisapersen) of December 27, 2015, and anticipate taking action in early January 2016.
Faron Pharmaceuticals Ltd (Faron), the clinical stage biopharmaceutical company, has announced the enrollment of the first patient in the phase III INTEREST clinical programme for Traumakine for the treatment of acute respiratory distress syndrome (ARDS). Faron is a drug discovery and development company focused on creating novel treatments for medical conditions with significant unmet needs.